Ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis

CDKN2A 肉瘤样癌 癌症研究 阶段(地层学) 生物 免疫组织化学 内科学 卵巢癌 突变 肿瘤科 病理 医学 卵巢癌 癌症 基因 遗传学 古生物学
作者
Yun Liang,Huajuan Ruan,Minghua Yu,Bingjian Lü
出处
期刊:Pathology [Elsevier BV]
卷期号:55 (7): 966-973 被引量:7
标识
DOI:10.1016/j.pathol.2023.08.001
摘要

Ovarian squamous cell carcinoma (SCC), particularly the sarcomatoid variant, arising from teratoma is a rare malignant tumour with unfavourable clinical outcomes. Its molecular genetic alterations have not been well-documented to date. This study aims to characterise the molecular features and to provide potential therapeutic targets in this rare entity. We analysed the clinicopathological and immunohistochemical features of six primary ovarian SCC. These cases were subject to targeted next-generation sequencing to detect genomic features. We found that all six ovarian SCC (four conventional and two sarcomatoid SCC) were associated with mature cystic teratomas. Patient 3 (FIGO stage IIIa) and Patient 4 (stage IIb) died of disease at 10 and 11 months, respectively. The remaining patients (three with stage I and one with IIc) including the two with sarcomatoid SCC, were alive with no evidence of disease at 28-72 months. All patients showed PD-L1 expression (tumour proportion score: range 10-78%, median 41%; combined positive score: range 12-85, median 42) and a high tumour mutation burden (range 13.4-25.7 mutations/Mb, median 16.5). The most frequently recurrent mutations included PIK3CA (4/6), TP53 (4/6), TERT promoter (4/6), CDKN2A (3/6). Mutations in homologous recombination repair pathway genes (BLM, ATM, BRCA1, BRIP1 and ATM) were found in 5/6 patients. The sarcomatoid SCC shared a similar mutational profile with conventional SCC, and no recurrent genetic mutations exclusively in sarcomatoid SCC were identified. Our study suggests the potential benefits of immune checkpoint inhibitors and/or PARP inhibitors in patients with primary ovarian SCC on account of PD-L1 expression and genomic features. Ovarian sarcomatoid SCC may be clonally related to the conventional SCC. A multiple-institutional, clinical and molecular study will consolidate these findings in the future.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
863发布了新的文献求助10
刚刚
2秒前
小俊完成签到,获得积分10
2秒前
要文献啊完成签到 ,获得积分10
4秒前
4秒前
7秒前
zzq完成签到,获得积分10
7秒前
JQ完成签到,获得积分10
7秒前
杨锦钰发布了新的文献求助20
9秒前
ThanhHuy发布了新的文献求助10
9秒前
香蕉觅云的应助被单薄枕头采纳,获得10
10秒前
HR完成签到,获得积分10
11秒前
烦烦烦发布了新的文献求助10
11秒前
11秒前
小白一枚完成签到,获得积分10
11秒前
西麓麓完成签到,获得积分10
11秒前
orixero的应助被Jingxue_ZX采纳,获得10
12秒前
12秒前
mimi发布了新的文献求助10
13秒前
大力的远望完成签到 ,获得积分10
14秒前
15秒前
molihuakai的应助被田12采纳,获得10
16秒前
17秒前
风吹麦浪的应助被XJY采纳,获得20
17秒前
sweet完成签到 ,获得积分10
18秒前
wg发布了新的文献求助10
18秒前
海绵宝宝完成签到 ,获得积分10
19秒前
20秒前
long0809发布了新的文献求助10
20秒前
星辰完成签到,获得积分20
21秒前
21秒前
22秒前
初晨发布了新的文献求助10
22秒前
orixero的应助被DW采纳,获得10
24秒前
平常的宛丝完成签到 ,获得积分10
24秒前
Dawn完成签到,获得积分10
24秒前
烟花的应助被rainy采纳,获得10
25秒前
Jeremy发布了新的文献求助10
25秒前
Aa发布了新的文献求助10
26秒前
fabian完成签到,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188339
求助须知:如何正确求助?哪些是违规求助? 9576127
关于积分的说明 21845709
捐赠科研通 7786389
什么是DOI,文献DOI怎么找? 3435292
关于科研通互助平台的介绍 2559588
邀请新用户注册赠送积分活动 2482196